CVS Health Corp


Market Cap$76.62B

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
CVS Health CorpCVS Health Corp10.54.11%10%0.20.9

Earnings Call Q4 2023

February 7, 2024 - AI Summary

CVS Health reported strong financial results for the fourth quarter of 2023, with revenues increasing by nearly 12% and adjusted EPS of $2.12.
The company revised its full-year 2024 guidance for adjusted EPS to at least $8.30 and cash flow from operations to at least $12 billion due to cautiousness around Medicare Advantage utilization trends.
Utilization pressure in Medicare Advantage continues to be a challenge, impacting the medical benefit ratio (MBR) and overall profitability of the business segment.

Exclusive for Stockcircle Pro members

Sign upSign Up

Target Price by Analysts

32.8% upsideCVS Health Target Price DetailsTarget Price

Current Fair Value

34% upside

Undervalued by 34% based on the discounted cash flow analysis.

Share Statistics

Market cap$76.62 Billion
Enterprise Value$127.67 Billion
Dividend Yield$2.5062 (4.11%)
Earnings per Share$5.7
Outstanding Shares1,255,372,972
Avg 30 Day Volume13,358,114


Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio10.47
Price to Sales0.21
Price to Book Ratio1.05
Enterprise Value to Revenue0.35
Enterprise Value to EBIT9.76
Enterprise Value to Net Income17
Total Debt to Enterprise0.5
Debt to Equity0.87

Revenue Sources

No data

Insider Trades

ESG Score

No data

About CVS Health Corp

CEO: Larry Merlo